Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells
about
NK Cells in HIV DiseaseThe role of NK cells in HIV-1 protection: autologous, allogeneic or both?Fc functional antibodies in humans with severe H7N9 and seasonal influenzaNK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative CounterpartsIncreased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.Small CD4 Mimetics Prevent HIV-1 Uninfected Bystander CD4 + T Cell Killing Mediated by Antibody-dependent Cell-mediated CytotoxicityWhat Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection.Potent In Vivo NK Cell-mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-bispecific and Hexavalent Broadly Neutralizing Fusion Protein.Beyond Viral Neutralization.Natural Killer cells in HIV-1 infection and therapy.Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
P2860
Q26752833-25307E04-3C9B-4CC7-A31A-C3733B873041Q26753146-94785533-2238-4519-B7B8-0BE9C144F5D8Q33877811-0C8225AA-875B-41A6-8BD5-020EBDA5B1CAQ36161508-26869C09-5883-4890-BD9D-5429973781D1Q36246252-F9E0F6D7-B66A-4C5E-B389-2B8A2CD1051CQ36538762-BB11B263-B7D6-459F-93F4-7C99EA9FBACBQ37034475-72F20691-9D00-4779-961F-58EFF9494769Q38453875-CE335B6A-DF4C-412C-B212-0002188B781EQ38725490-D1068BC5-3CFB-4103-955E-391E2253FD0BQ38812544-0BFCC8B8-D249-4760-9CBB-3876D94C8FDDQ39189458-939E0C37-6BCC-42A0-B061-EE4E76CB55C0Q40052007-184C52CF-3AE9-4BC5-933C-55DA74384214Q40088529-3241321A-6F15-4B4D-A0C4-847515F10FE8Q40088787-51212366-C516-4520-B061-82EF796755F5Q40373085-044DD2F6-8007-475B-BF84-B9701ADEC86EQ41934634-E9BA00E0-03D0-4C5E-A4B8-869D8B4EA120Q58724429-F8CC8C06-B5A3-4C47-A39C-4454FC29BEBA
P2860
Slaying the Trojan horse: natural killer cells exhibit robust anti-HIV-1 antibody-dependent activation and cytolysis against allogeneic T cells
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@ast
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@en
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@nl
type
label
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@ast
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@en
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@nl
prefLabel
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@ast
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@en
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@nl
P2093
P2860
P50
P356
P1433
P1476
Slaying the Trojan horse: natu ...... sis against allogeneic T cells
@en
P2093
Jonathan Richard
Matthew S Parsons
Shayarana L Gooneratne
P2860
P304
P356
10.1128/JVI.02461-14
P407
P577
2014-10-15T00:00:00Z